Literature DB >> 31228247

Effect of reducing dietary advanced glycation end products on obesity-associated complications: a systematic review.

Priscila V M Ribeiro1, Juliana F Tavares1, Mirian A C Costa1, Jéssica B Mattar1, Rita C G Alfenas1.   

Abstract

CONTEXT: Consumption of dietary advanced glycation end products (AGEs) is associated with oxidative stress, inflammation, and other chronic conditions commonly associated with obesity.
OBJECTIVE: To analyze the effects of dietary AGEs on complications associated with obesity. DATA SOURCES: This systematic review was conducted and reported according to PRISMA guidelines. The PubMed, Cochrane, and Scopus databases were searched, using the terms "advanced glycation end products," "overweight," and "obesity." The last search was performed in October 2018. DATA EXTRACTION: Six studies that evaluated the effects of low-AGE and high-AGE diets were included in the review. The duration of the studies ranged from 1 day to 12 weeks. A comparison of all the compiled data was conducted by the authors. DATA ANALYSIS: Circulating and urinary AGE markers, besides soluble receptor for AGEs, were considered as the primary outcomes. The secondary outcomes were cardiometabolic, inflammatory, glycemic, anthropometric, and renal markers.
CONCLUSIONS: AGE-RAGE interactions can activate the NF-κB (nuclear factor kappa B) signaling pathway and inhibit the PI3K-AKT pathway in adipocytes, which may explain their association with chronic diseases. This interaction can be considered as a novel explanation for the pathogenesis of obesity. AGEs can also be used as a biomarker for monitoring responses to dietary interventions in overweight and obese people. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. CRD42018082745.
© The Author(s) 2019. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 NF-κBzzm321990 ; zzm321990 RAGEzzm321990 ; zzm321990 ROSzzm321990 ; zzm321990 advanced glycation end productzzm321990 ; zzm321990 dietary AGEszzm321990 ; zzm321990 dietary recommendationszzm321990 ; zzm321990 insulin resistancezzm321990 ; zzm321990 obesityzzm321990 ; zzm321990 pathway PI3K-AKTzzm321990 ; zzm321990 renal injury and endothelial dysfunctionzzm321990

Mesh:

Substances:

Year:  2019        PMID: 31228247     DOI: 10.1093/nutrit/nuz034

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  4 in total

1.  The impact of low advanced glycation end products diet on obesity and related hormones: a systematic review and meta-analysis.

Authors:  Mohammad Hassan Sohouli; Elham Sharifi-Zahabi; Abolfazl Lari; Somaye Fatahi; Farzad Shidfar
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

2.  Personalized diet study of dietary advanced glycation end products (AGEs) and fatty acid desaturase 2 (FADS2) genotypes in obesity.

Authors:  Mahsa Mahmoudinezhad; Mahdieh Abbasalizad Farhangi; Houman Kahroba; Parvin Dehghan
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

3.  Clinical health markers in dogs fed raw meat-based or commercial extruded kibble diets.

Authors:  Kristina Hiney; Lara Sypniewski; Pratyaydipta Rudra; Adel Pezeshki; Dianne McFarlane
Journal:  J Anim Sci       Date:  2021-06-01       Impact factor: 3.159

4.  Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis.

Authors:  Mirko Luketin; Maja Mizdrak; Dijana Boric-Skaro; Dinko Martinovic; Daria Tokic; Marino Vilovic; Daniela Supe-Domic; Tina Ticinovic Kurir; Josko Bozic
Journal:  Biomolecules       Date:  2021-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.